Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.3K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

229
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
229
Pharmacovigilance01:19

Pharmacovigilance

1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

402
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
402
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

872
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
872

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating 'k-land': a qualitative exploration of participants' experiences of ketamine-assisted psychotherapy for methamphetamine use disorder.

Frontiers in psychiatry·2026
Same author

A comprehensive overview of paracetamol poisoning admissions and long-term outcomes in New South Wales, Australia: a retrospective linked data cohort (PAVLOVA-3).

The Lancet regional health. Western Pacific·2026
Same author

"Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use Disorder.

AJNR. American journal of neuroradiology·2026
Same author

International Trends in Dental Opioid Prescriptions.

JAMA network open·2026
Same author

Hospital-Wide Quality Assessment Using All-Condition Versus Summed-Condition Risk Adjustment.

Health services research·2026
Same author

Unlocking clinical narratives: how natural language processing and artificial intelligence can address data deficits and mitigate health inequities in urgent and emergency care.

Emergency medicine journal : EMJ·2026

Related Experiment Video

Updated: Mar 3, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K

A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data:

Jonathan Brett1, Adam G Elshaug2, R Sacha Bhatia3,4

  • 1Medicines Policy Research Unit, Centre for Big Data Research in Health, University of New South Wales, Level 1, AGSM Building (G27), Sydney, NSW, 2052, Australia.

Implementation Science : IS
|May 5, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces a new methodology to identify and quantify low-value prescribing practices in Australia. The research aims to improve healthcare safety and resource allocation by analyzing routinely collected health data.

Keywords:
Low-value careMedicinesPrescribingProtocolRoutinely collected data

More Related Videos

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

13.3K

Related Experiment Videos

Last Updated: Mar 3, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

13.3K

Area of Science:

  • Pharmacoepidemiology
  • Health Services Research
  • Health Policy

Background:

  • Growing emphasis on healthcare safety, quality, and resource allocation necessitates identification of low-value medical practices.
  • Existing research on low-value care predominantly focuses on tests and procedures, with limited attention to prescribing practices.
  • Routinely collected health data offers a valuable resource for quantifying low-value practices at a population level.

Purpose of the Study:

  • To develop and apply a systematic methodology for selecting and quantifying low-value prescribing practices within Australian routinely collected health data.
  • To establish a framework for measuring the prevalence, costs, and downstream health consequences of low-value prescribing.
  • To provide a transparent and adaptable approach for harmonizing international efforts in measuring low-value prescribing.

Main Methods:

  • Cataloguing international low-value prescribing practices.
  • Translating identified practices into quantifiable indicators applicable to Australian health data.
  • Utilizing Australian health data to determine the prevalence, costs, and health impacts of low-value prescribing.

Main Results:

  • The research protocol has received necessary ethics and data access approvals.
  • A systematic methodology for quantifying low-value prescribing in Australia has been established.
  • The study is positioned to generate data on the scale and impact of low-value prescribing.

Conclusions:

  • The developed methodology offers a transparent and systematic approach to quantifying low-value prescribing.
  • This research provides a foundation for harmonizing international efforts to measure and reduce low-value prescribing.
  • Findings will be disseminated through peer-reviewed publications and international forums to guide policy and practice.